… In this study, we performed a comprehensive systematic review to identify all RCTs involving
the use of any ALK inhibitor to treat ROS1 or ALK-positive NSCLC, and we used NMA …

… non-small cell lung cancer (NSCLC). However, the benefit seems to be dependent on the
drugs used in the chemotherapy regimens. This systematic review … in this systematic review, …

Introduction The importance of non-small cell lung cancer (NSCLC) histologic subtype has
increased during the last few decades because of an unprecedented shift in epidemiology …

… regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. …
factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. …

… Programmed cell death protein-1- checkpoint blockers have recently been approved as
second-line treatment for advanced non–small-cell lung cancer (NSCLC). Unfortunately, only a …

… Nonetheless, the lack of improvement in HRQoL seen in this review is consistent with the
results from a systematic review on exercise training for women with breast cancer [65]. Markes …

… The Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) … for this
systematic review. At the time of the writing of this article, there was no known review protocol …

… Nineteen studies with a total of 1066 patients were included in this systematic review.
Neoadjuvant immunotherapy was associated with improved pathological response rates, …

… We adopted a systematic review method to systematically search and analyze the NSCLC
guidelines worldwide. We objectively reviewed the differences in recommendations for …

… addicted non-small-cell lung cancer (NSCLC) have been deeply investigated. To rank
the available therapeutic options, we carried out a systematic review and Bayesian meta-analysis. …